These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18656274)

  • 41. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.
    Kereiakes DJ; Berkowitz SD; Lincoff AM; Tcheng JE; Wolski K; Achenbach R; Melsheimer R; Anderson K; Califf RM; Topol EJ
    Am Heart J; 2000 Jul; 140(1):74-80. PubMed ID: 10874266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome.
    Bagur R; Bertrand OF; Rodés-Cabau J; Rinfret S; Larose E; Tizón-Marcos H; Gleeton O; Nguyen CM; Roy L; Costerousse O; De Larochellière R
    Am J Cardiol; 2009 Sep; 104(5):624-9. PubMed ID: 19699334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
    Ahmed TA; Atary JZ; Wolterbeek R; Hasan-Ali H; Abdel-Kader SS; Schalij MJ; Jukema JW
    J Interv Cardiol; 2012 Feb; 25(1):1-9. PubMed ID: 22059390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial.
    Stone GW; Witzenbichler B; Godlewski J; Dambrink JH; Ochala A; Chowdhary S; El-Omar M; Neunteufl T; Metzger DC; Dizon JM; Wolff SD; Brener SJ; Mehran R; Maehara A; Gibson CM
    Circ Cardiovasc Interv; 2013 Oct; 6(5):527-34. PubMed ID: 24084626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction.
    Piccolo R; Galasso G; Eitel I; Dominguez-Rodriguez A; Iversen AZ; Gu YL; Abreu-Gonzalez P; de Smet BJ; Esposito G; Windecker S; Thiele H; Piscione F
    Am J Cardiol; 2016 Dec; 118(12):1798-1804. PubMed ID: 27756477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter randomized study to evaluate intracoronary abciximab with the ClearWay catheter to improve outcomes with Lysis (IC ClearLy): trial study design and rationale.
    Sardella G; Sangiorgi GM; Mancone M; Colantonio R; Donahue M; Politi L; Bucciarelli-Ducci C; Carbone I; Francone M; Ligabue G; Fiocchi F; Di Roma A; Benedetti G; Lucisano L; Stio RE; Agati L; Modena MG; Genuini I; Fedele F; Gibson M
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):529-35. PubMed ID: 19918189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function.
    Pinkau T; Ndrepepa G; Kastrati A; Mann JF; Schulz S; Mehilli J; Schömig A
    Cardiology; 2008; 111(4):247-53. PubMed ID: 18434733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis.
    Moustapha A; Assali AR; Sdringola S; Yusuf SW; Vaughn WK; Fish RD; Schroth GW; Krajcer Z; Rosales OR; Smalling RW; Anderson HV
    Catheter Cardiovasc Interv; 2002 Jun; 56(2):184-7. PubMed ID: 12112910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
    Ndrepepa G; Kastrati A; Mehilli J; Neumann FJ; ten Berg J; Bruskina O; Dotzer F; Seyfarth M; Pache J; Dirschinger J; Berger PB; Schömig A
    Eur Heart J; 2008 Feb; 29(4):455-61. PubMed ID: 18158289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Hansen PR; Iversen A; Abdulla J
    J Invasive Cardiol; 2010 Jun; 22(6):278-82. PubMed ID: 20516508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials.
    De Rosa S; Caiazzo G; Torella D; Indolfi C
    Int J Cardiol; 2013 Sep; 168(2):1298-305. PubMed ID: 23273690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
    Beeres SL; Oemrawsingh PV; Warda HM; Bechan R; Atsma DE; Jukema JW; van der Wall EE; Schalij MJ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):478-83. PubMed ID: 15973655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissolution of thrombus formed during direct coronary angioplasty with a single 10 mg intracoronary bolus dose of abciximab.
    Thuraisingham S; Tan KH
    Int J Clin Pract; 1999 Dec; 53(8):604-7. PubMed ID: 10692754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Randomized Double-Blind Placebo-Controlled Study Comparing Intracoronary Versus Intravenous Abciximab in Patients With ST-Elevation Myocardial Infarction Undergoing Transradial Rescue Percutaneous Coronary Intervention After Failed Thrombolysis.
    Bertrand OF; Larose É; Bagur R; Maes F; Gaudreault V; Noël B; Barbeau G; Déry JP; Pirlet C; Costerousse O;
    Am J Cardiol; 2018 Jul; 122(1):47-53. PubMed ID: 29699748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracoronary administration of abciximab during percutaneous coronary interventions: should this be the routine and preferred approach?
    Sharma S; Makkar R; Lardizabal J
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):136-41. PubMed ID: 16891291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the bioequivalence of brand and biogeneric formulations of abciximab for the treatment of acute coronary syndrome: a prospective, open-label, randomized, controlled study in Korean patients.
    Choi DH; Suh JW; Park KW; Kang HJ; Kim HS
    Clin Ther; 2009 Aug; 31(8):1804-11. PubMed ID: 19808139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes.
    Prati F; Capodanno D; Pawlowski T; Ramazzotti V; Albertucci M; La Manna A; Di Salvo M; Gil RJ; Tamburino C
    JACC Cardiovasc Interv; 2010 Sep; 3(9):928-34. PubMed ID: 20850091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT).
    Nakagawa Y; Nobuyoshi M; Yamaguchi T; Meguro T; Yokoi H; Kimura T; Hosoda S; Kanmatsuse K; Matsumori A; Sasayama S
    Circ J; 2009 Jan; 73(1):145-51. PubMed ID: 19023152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.